observed in pancreatic ductal adenocarcinoma cells that the MEK signal pathway sustains the high expression level of SLC31A1 by curbing the expression level of miR-124, which can suppress the SLC31A1 expression by binding SLC31A1 3′ UTR [176]. Here, SLC31A1 is linked to pancreatic ductal adenocarcinoma.